Jump Financial »

Aeglea Biotherapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $454k 27k 16.76
2024-06-30 $1.5M 65k 23.51
2024-03-31 $865k 23k 37.93

More positions owned by Jump Financial

Invesco QQQ Trust Series 1 Etf (QQQ)
iShares Russell 2000 ETF Etf (IWM)
NVIDIA Corp Common Stock (NVDA)
SPDR S&P 500 ETF Trust Etf (SPY)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Amazon.com Common Stock (AMZN)
Meta Platforms Common Stock (META)
Consumer Discretionary Select Sector SPDR Fund Etf (XLY)
Broadcom Common Stock (AVGO)
iShares U.S. Treasury Bond ETF Etf (GOVT)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)

View all positions for Jump Financial

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics